Filling the need for trusted information on national health issues

NIH Official Discusses Need To Issue Exclusive License To Drug Company For Zika Vaccine Development With U.S. House, Senate Staff

CQ HealthBeat: NIH Tries to Ease Concerns About Zika Vaccine Deal
“The federal government is considering granting a pharmaceutical company an exclusive license to further develop a taxpayer-funded vaccine for the Zika virus, just weeks after a similar arrangement was scuttled following blowback from health groups and lawmakers. … In a pair of conference calls with House and Senate staff members, [NIAID Director Anthony] Fauci made a case for why the government needs industry partners to get a Zika vaccine to market…” (Siddons, 10/16).